A DNA Repair Protein BRCA1 as a Potentially Molecular Target for the Anticancer Platinum Drug Cisplatin

QR Code

A DNA Repair Protein BRCA1 as a Potentially Molecular Target for the Anticancer Platinum Drug Cisplatin

None

Saved in:

Bibliographic Details
Main Author:	Ratanaphan, Adisorn
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/23152
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BRCA2 Mutations and Consequences for DNA Repair
by: Brown, Erika T.
Published: (2011)

VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells
by: Martina Raudenska, et al.
Published: (2017-09-01)

Structure-Function Relationship of DNA Repair Proteins: Lessons from BRCA1 and RAD51 Studies
by: Boutou, Effrossyni, et al.
Published: (2011)

Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
by: Ahmad, Aamir, et al.
Published: (2012)

RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR
by: M. M. Tsyganov, et al.
Published: (2019-06-01)

The Potential Roles of DNA-Repair Proteins in Centrosome Maintenance
by: Shimada, Mikio, et al.
Published: (2011)

QSAR, Molecular Docking, and Pharmacokinetic Studies of 1,8-Naphthyridine Derivatives as Potential Anticancer Agents Targeting DNA Topoisomerase II
by: Garba Suleiman, et al.
Published: (2025-01-01)

Comparative Analysis between Two Anticancer Drugs: Platinum Complexes and Camptothecin in Ovarian Cancer Treatment
by: Zhou Yuhan
Published: (2025-01-01)

Overview of Roles of Novel Components in the Regulation of DNA Damage Repair in BRCA1-Deficient Cancers: An Update
by: Nhat Nguyen, et al.
Published: (2025-04-01)

Drug design of an anticancer drug: QSAR modeling, and molecular docking
by: Sedigheh Aghayari
Published: (2025-09-01)

Roles of DNA Repair Proteins in Telomere Maintenance
by: Ueno, Masaru
Published: (2011)

Application of Host Cell Reactivation in Evaluating the Effects of Anticancer Drugs and Environmental Toxicants on Cellular DNA Repair Activity in Head and Neck Cancer
by: Tsai, Yi-Shan, et al.
Published: (2011)

DNA Double-Strand Breaks Repair and Signaling of Human Gliomas and Normal Brain Cells in Response to Radiation: Potential Impact of the ATM-and BRCA1- Dependent Pathways
by: Granzotto, Adeline, et al.
Published: (2011)

Cisplatin‐Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions
by: Ko‐Chieh Huang, et al.
Published: (2025-06-01)

Significance, Mechanisms, and Progress of Anticancer Drugs Targeting HGF-Met
by: Sakai, Katsuya, et al.
Published: (2011)

Microfaradaic Electrochemical Biosensors for the Study of Anticancer Action of DNA Intercalating Drug: Epirubicin
by: Pitre, Krishna, et al.
Published: (2011)

Molecular analysis of three DNA mismatch repair protein variants in Chinese families with suspected Lynch syndrome
by: Juyi Li, et al.
Published: (2025-07-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE
by: A. M. Amjad
Published: (2021-06-01)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

Transcriptional Functions of DNA Repair Proteins Involved in Premature Aging
by: Assfalg, Robin, et al.
Published: (2011)

The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
by: Köberle, Beate, et al.
Published: (2012)

ANTICANCER DNA VACCINATION: PRINCIPLE AND PERSPECTIVES OF THE METHOD
by: M. V. Stegantseva, et al.
Published: (2017-05-01)

Non-Steroidal Anti-Inflammatory Drugs, DNA Repair and Cancer
by: Dibra, Harpreet K., et al.
Published: (2011)

Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia
by: Totka Dodevska
Published: (2025-07-01)

Nucleases of Metallo-Beta-Lactamase and Protein Phosphatase Families in DNA Repair
by: Fernandez, Francisco J, et al.
Published: (2011)

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023-06-01)

DNA Replication in Repair
by: McCabe, Kevin M.
Published: (2011)

Mitochondrial DNA Repair
by: Martin, Sarah A.
Published: (2011)

Molecular biological subtypes of breast cancer in BRCA1 mutation carriers
by: N. I. Pospekhova, et al.
Published: (2021-01-01)

Approaches to anticancer therapy based on modulation of DNA methylation
by: V. P. Maksimova, et al.
Published: (2024-09-01)

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations
by: Sijongesonke Peter, et al.
Published: (2025-05-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

Identification of a Novel Signaling Platform as a Cisplatin Target in Kidney Injury
by: Alice Lu, et al.
Published: (2025-06-01)

DNA Repair Perspectives in Thyroid and Breast Cancer: The Role of DNA Repair Polymorphisms
by: Silva, Susana N., et al.
Published: (2011)

From the Molecular Biology to the Gene Therapy of a DNA Repair Syndrome: Fanconi Anemia
by: Río, Paula, et al.
Published: (2011)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics
by: Muhammad Uzair Khan, et al.
Published: (2025-05-01)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020-12-01)